18591-82-7

Usage

Uses

Used in Organic Synthesis:
3-Amino-6-Methylpyridazine is used as a building block in the synthesis of various organic compounds. Its unique structure allows for the creation of a wide range of molecules with different properties and applications.
Used in Pharmaceutical Industry:
3-Amino-6-Methylpyridazine is used as an intermediate in the production of pharmaceuticals. Its presence in the molecular structure of certain drugs contributes to their therapeutic effects.
Used in Agrochemical Applications:
3-Amino-6-Methylpyridazine is used as a component in the formulation of agrochemicals, such as pesticides and herbicides. Its inclusion in these products helps to enhance their effectiveness in controlling pests and weeds.
Used in Dyestuff Industry:
3-Amino-6-Methylpyridazine is used as a raw material in the production of dyes and pigments. Its chemical properties enable the creation of vibrant and stable colors for various applications, including textiles, plastics, and inks.
Safety Precautions:
Due to the potentially harmful effects of 3-Amino-6-Methylpyridazine, it is essential to observe safety precautions when handling and storing this chemical. It can pose hazards if ingested, inhaled, or if it contacts the skin or eyes. To prevent toxic exposure and environmental pollution, it should be disposed of in accordance with local, regional, national, and international regulations.

InChI:InChI=1/C4H4IN3/c5-3-1-2-4(6)8-7-3/h1-2H,(H2,6,8)

Upstream product

• 1121-79-5 3-chloro-6-methylpyridazine 

Downstream Products

• 5433-63-6 sulfamethoxypyridazine 
• 65610-28-8 6-methyl-2-phenylimidazo<1,2-b>pyridazine 
• 188692-63-9 6-Methyl-2-p-tolyl-imidazo[1,2-b]pyridazine 
• 100193-48-4 benzyl-(6-methyl-pyridazin-3-yl)-amine 
• 570416-57-8 2-ethyl-6-methylimidazo[1,2-b]pyridazine 
• 1402608-78-9 tert-butyl {1-[4-(6-methyl-3-phenylimidazo[1,2-b]pyridazin-2-yl)-phenyl]cyclobutyl}carbamate 
• 1476848-33-5 2-(4-(benzyloxy)-6-methoxybenzofuran-2-yl)-6-methylimidazo[1,2-b]pyridazine 
• 1620332-38-8 N-benzyl-2,6-dimethylimidazo[1,2-b]pyridazine-3-carboxamid 

Relevant academic research and scientific papers

Compounds for treating spinal muscular atrophy

Provided herein are compounds, compositions thereof and uses therewith for treating spinal muscular atrophy. In a specific embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN2 into mRNA that is transcribed from the SMN2 gene. In another specific embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN1 into mRNA that is transcribed from the SMN1 gene. In yet another embodiment, provided herein are compounds of a form that may be used to modulate the inclusion of exon 7 of SMN1 and SMN2 into mRNA that is transcribed from the SMN1 and SMN2 genes, respectively.

IMIDAZOPYRIDAZINE COMPOUNDS

The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I): pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.

IMIDAZOPYRIDAZINE COMPOUNDS

The present invention relates to novel substituted imidazo[1,2-b] pyridazine compounds of Formula (I) pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.

N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists

The invention concerns pharmaceutically useful N-heterocyclyl sulphonamide derivatives, their pharmaceutically acceptable salts, processes for their manufacture, their use for antagonising one or more actions of endothelin in a human or other warm-blooded animal, their use in methods of treatment of diseases or medical conditions in which elevated or abnormal levels of endothelin play a significant causative role.